TY - JOUR
T1 - MRI presentation of hepatocellular carcinoma in non-alcoholic steatohepatitis (NASH)
AU - Al-Sharhan, Fatima
AU - Dohan, Anthony
AU - Barat, Maxime
AU - Feddal, Adlane
AU - Terris, Benoit
AU - Pol, Stanislas
AU - Mallet, Vincent
AU - Soyer, Philippe
N1 - Publisher Copyright:
© 2019 Elsevier B.V.
PY - 2019/10/1
Y1 - 2019/10/1
N2 - Purpose: To describe the magnetic resonance imaging (MRI) features of hepatocellular carcinoma (HCC) in patients with non-alcoholic steatohepatitis (NASH). Methods: MRI examinations of 21 patients with HCC and NASH were analyzed by two observers. There were 18 men and 3 women with a mean age of 67.9 ± 10.2 (SD) years (range: 36–85 years). Images were qualitatively and quantitatively analyzed with respect to imaging presentation. Results: HCC presented as a single tumor in 13/21 patients (62%), with a mean longest diameter of 26.9 ± 20.2 (SD) mm (range: 12–88 mm); 17/30 HCC (57%) had a largest diameter <20 mm. A signal drop between in- and out-of-phase T1-weighted MR images was observed in 16/30 HCC nodules (53%). All HCC nodules (30/30; 100%) showed hyperenhancement on arterial phase images and 12/30 HCC nodules (40%) did not show a wash-out on portal or delayed phase images. Encapsulation was observed in 18/30 HCC nodules (60%). MRI findings consistent with liver cirrhosis were present in 16/21 patients (76%). Conclusions: Our results show that 57% of HCC in NASH can present as a lesion smaller than 20 mm and 40% do not display wash-out. These results suggest that classical imaging criteria developed for noninvasive diagnosis of HCC should be applied with caution to HCC in patients with NASH.
AB - Purpose: To describe the magnetic resonance imaging (MRI) features of hepatocellular carcinoma (HCC) in patients with non-alcoholic steatohepatitis (NASH). Methods: MRI examinations of 21 patients with HCC and NASH were analyzed by two observers. There were 18 men and 3 women with a mean age of 67.9 ± 10.2 (SD) years (range: 36–85 years). Images were qualitatively and quantitatively analyzed with respect to imaging presentation. Results: HCC presented as a single tumor in 13/21 patients (62%), with a mean longest diameter of 26.9 ± 20.2 (SD) mm (range: 12–88 mm); 17/30 HCC (57%) had a largest diameter <20 mm. A signal drop between in- and out-of-phase T1-weighted MR images was observed in 16/30 HCC nodules (53%). All HCC nodules (30/30; 100%) showed hyperenhancement on arterial phase images and 12/30 HCC nodules (40%) did not show a wash-out on portal or delayed phase images. Encapsulation was observed in 18/30 HCC nodules (60%). MRI findings consistent with liver cirrhosis were present in 16/21 patients (76%). Conclusions: Our results show that 57% of HCC in NASH can present as a lesion smaller than 20 mm and 40% do not display wash-out. These results suggest that classical imaging criteria developed for noninvasive diagnosis of HCC should be applied with caution to HCC in patients with NASH.
KW - Chronic liver disease
KW - Hepatocellular carcinoma (HCC)
KW - Magnetic resonance imaging (MRI)
KW - Malignant tumor
KW - Tissue characterization
UR - http://www.scopus.com/inward/record.url?scp=85072038564&partnerID=8YFLogxK
U2 - 10.1016/j.ejrad.2019.108648
DO - 10.1016/j.ejrad.2019.108648
M3 - Article
C2 - 31521875
AN - SCOPUS:85072038564
SN - 0720-048X
VL - 119
JO - European Journal of Radiology
JF - European Journal of Radiology
M1 - 108648
ER -